AstraZeneca

AstraZeneca

AstraZeneca is a multinational pharmaceutical and biopharmaceutical company that has its headquarters in Cambridge, United Kingdom as of 2013. It also does research and development in several sites and has a number of other locations as well. The company is one of the primary listings on the London Stock exchange and has a secondary listing on the New York Stock Exchange. As of 2017, AstraZeneca employed over 59,000 people. Some of the employment opportunities include jobs like a field health outcomes director, field reimbursement manager, senior administrative coordinator, automation delivery architect, medical affairs leader, associate director of biostatistics and oncology, and global consuming marketing director.

The company was founded as Astra A.B. in 1913 in Sweden by several hundred doctors and apothecaries. However, in 1993, the British Chemicals Company ICI merged its pharmaceuticals company with its agrochemicals and specialties business to create the Zeneca group. In 1999, these two companies formed the newly named AstraZeneca. The company has a relatively large portfolio of products including major disease areas like cancer, cardiovascular disease, gastrointestinal, infection, neuroscience, respiratory, and inflammation. The most recent major event take place was a collaborative relationship starting in 2004 between AstraZeneca and Cambridge Antibody technology followed by the acquisition of Cambridge for 702 million pounds in 2006.

This company has its headquarters in the United Kingdom, but it has offices in the United States, throughout the UK, in Sweden, France, China, Germany, Australia, New Zealand, Japan, India, Canada, Brazil, Italy, Mexico, Russia, Poland, and Spain. They are a publicly traded company and reported $22.34 billion in revenue as of the 2017 fiscal year. AstraZeneca also reported revenue per share at $8.82 and a quarterly revenue growth of just over two percent. Their net income reported was $2.68 billion.